Pharmaceutical Patent Prosecution Primer
Author Dr. Brian TrinqueLathrop Gage LLP, Boston MA Presentation 256th ACS National Meeting – BostonMonday, August 20, 2018, 9AM“Developments in
257th Meeting Highlights
257th Meeting Highlights
Boston, MA | August 18-22, 2018
What Constitutes an Inventor? A Review of Federal Circuit Case Law
Author Dr. Andrew EhleLathrop Gage LLP, Boston MA Presentation 256th ACS National Meeting – BostonMonday, August 20, 2018, 9AM“Developments in
Obviousness, the CAFC, and Second Generation Filing Strategies
Author Dr. Benjamin A. Vaughan and Dr. Nicole SassuLathrop Gage LLP, Boston MA Presentation 256th ACS National Meeting – BostonMonday,
Definiteness and the Medicines Co. and Forest Labs. Decisions
Author Dr. Brian TrinqueLathrop Gage LLP, Boston MA Presentation 256th ACS National Meeting – BostonMonday, August 20, 2018, 9AM“Developments in
Extensions to patent term in the U.S. and worldwide
Author Richard BoneMcDermott Will & Emery LLP, Menlo Park, CA Presentation 256th ACS National Meeting – BostonMonday, August 20, 2018,
Patent term extension in the U.S.
Author Kristin Connarn, McDermottWill & Emery LLP, Boston, MA Presentation 256th ACS National Meeting – BostonMonday, August 20, 2018, 2:15PM“Extensions
Supplementary protection certificates in the European Union
Author Isobel FinnieHaseltine Lake LLP, Bristol, UK Presentation 256th ACS National Meeting – BostonMonday, August 20, 2018, 2:15PM“Extensions to Patent
Patent term extensions and data exclusivity in Australia, New Zealand and South East Asia
Author Jess GledhillFB Rice, Sydney, New South Wales John LandellsFB Rice, Melbourne, Victoria, Australia Presentation 256th ACS National Meeting –
Patent term adjustment in the U.S.
Author Richard BoneMcDermott Will & Emery LLP, Menlo Park, CA Presentation 256th ACS National Meeting – BostonMonday, August 20, 2018,